Android app Apple app link

Pyxis Oncology, Inc. (PYXS) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$1.35
Day's range
$1.51

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
09/10/2026 H.C. Wainwright Swayampakula Ramakanth $8.00 $3.38   136.69%
09/10/2026 Wedbush Robert Driscoll $8.00 $3.38   136.69%
07/02/2026 Leerink Partners Jeffrey La Rosa $7.00 $2.85   145.61%
05/05/2026 Wedbush Robert Driscoll $6.00 $1.76   240.91%
12/18/2025 RBC Capital Leonid Timashev $5.00 $1.73   189.02%
11/24/2025 Stephens Sudan Loganathan $8.00 $4.80   66.67%
11/04/2025 Guggenheim Bradley Canino $7.00 $3.81   83.73%
08/16/2024 H.C. Wainwright Swayampakula Ramakanth $7.00 $3.52   98.86%
08/07/2024 Stifel Nicolaus Bradley Canino $10.00 $3.13   219.49%
05/07/2024 Jefferies Farzin Haque $10.00 $4.31   132.02%

Pyxis Oncology Inc FAQ's

Pyxis Oncology Inc has been rated by research analysts at H.C. Wainwright, Wedbush, Leerink Partners, RBC Capital, Stephens, Guggenheim in the past 90 days.

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.